HOME

TheInfoList



Click Here for Items Related To - 5F-CUMYL-PEGACLONE
OR:
5F-CUMYL-PEGACLONE on:   [Wikipedia]   [Google]   [Amazon]

5F-CUMYL-PEGACLONE (5F-SGT-151, SGT-269) is a gamma-carboline based
synthetic cannabinoid Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that Binding affinity, bind to the same receptors to which cannabinoids (Tetrahydrocannabinol, THC, Cannabidiol, CBD and many others) in cannabis plants attach. Th ...
that has been sold as a
designer drug A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
, first being identified in Germany in 2017. It acts as a potent full agonist of the CB1 receptor. It appears to be more toxic than related compounds such as
CUMYL-PEGACLONE CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug. The gamma-carboline core structure seen in CUMYL-PEGACLONE had not previously been encountered in a designer cannabinoid, though it ...
, and has been linked to numerous serious adverse reactions, some fatal.


See also

*
5F-CUMYL-PINACA 5F-CUMYL-PINACA (also known as SGT-25 and sometimes sold in e-cigarette form as C-Liquid) is an indazole-3-carboxamide based synthetic cannabinoid. 5F-CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with the original patent ...
*
CUMYL-5F-P7AICA 5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo ,3-byridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015. See also * 5F-A-P7AI ...


References

Cannabinoids Designer drugs Gamma-Carbolines {{cannabinoid-stub